Health & bio

Novo Nordisk Wegovy Tablet Hits 600K March Prescriptions; First-Mover Advantage

Novo Nordisk Wegovy oral formulation surpassed 600K prescriptions in March, ~3 months ahead of Lilly Foundayo launch. Price and access competition intensifying.

Primary sources · 1

CNBC

← View the full 2026-04-30 (Thursday) issue

What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →